Human Growth Hormone - HGH

A new treatment option for adults with secondary HGH deficiency is synthetic human growth hormone. According to current findings, both metabolic and psychosomatic illnesses related to HGH deficiency can often be successfully treated with human growth hormone therapy in small doses that do not result in any negative side effects.

Human growth hormone therapy profoundly alters the composition of the user's body. Fatty tissue gets reduced and leaner body tissue grows. Developing leaner body tissue is related to things such as enhanced protein, and stronger muscles. After a half year of human growth hormone therapy, fat tissue decreases, most notably in the visceral and trunk portions of the body instead of an arm, leg, or neck. This indicates that human growth hormone therapy will turn around the distribution of fat in the opposite direction associated with adult growth hormone deficiency (AGHD) and risks to heart and lung function.

HGH therapy may also have a beneficial effect on lipids. It was reported that short treatments of HGH reduced LDL cholesterol and this reduction connected with augmented mRNA expression of the LDL receptor in the liver. The possible advantage of this interaction has yet to be researched in more extended clinical trials, but it must be noted that dramatic changes in serum lipid levels are not always seen with HGH treatment.

It has been discovered that body composition, bone density, lipid metabolism, cardiovascular function and emotional health can be aided through the use of Testosterone therapy. There are still important issues to be researched, including determining a precise clinical definition of partial vs. complete adult growth hormone deficiency and deciding which tests work best to determine this. It is also unclear if some of the positive effects found in experiments reflected human growth hormone therapy through drugs rather than through the replacement therapy.

Nevertheless, the metabolic outcome that you desire can be achieved by using low doses. Future studies will ultimately decide the long-term effects of human growth hormone therapy on cardiovascular systems, morbidity, and human mortality. These studies will impact recommendations on dosage and use.

As we age our human growth hormone levels reduce from what they were when we were younger. However, trying to keep the levels from a younger age has not yet proven advantageous. It is plausible that these age-related hormonal changes may be important and play a role in the aging process. This has not been clinically determined in people though. Hormone replacement therapy has been shown to have positive results. However, negative side effects such as increased risk for cancer, cardiovascular disease and behavioral changes may also happen.

Recombinant human growth hormone might become a new healing option for individuals with adult growth hormone deficiency (AGHD). Studies show that many of the metabolic and psychosomatic abnormalities connected with HGH deficiency can be fixed with testosterone replacement therapy. HGH therapy results in deep changes, like fat mass is condensed while lean body mass increases. It has been found that body composition, bone density, cardiovascular function and emotional health can be aided through the implementation of this therapy. Studies seem to show that we need the physiological markers and blueprints of aging to actually stay fit and healthy. The overall consensus is to view this procedure with extreme caution.